[Featured Stock] Access Bio, Has the Surge Stopped?... 8% Sharp Drop
[Asia Economy Reporter Minji Lee] Access Bio, which resumed trading, plunged 8% during the session.
At 10:02 AM on the 21st, Access Bio was traded at 46,050 KRW on the KOSDAQ market, down 7.44% from the previous session. Access Bio, which resumed trading that day, initially rose to 62,900 KRW, marking an all-time high, but the stock price also fell to 34,850 KRW.
Access Bio surged about 2300% this year on expectations for its COVID-19 diagnostic kit business. Its Q2 earnings recorded 1.3 billion KRW, turning profitable compared to the same period last year.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- After Topping 8,000 Instead of Hitting 10,000... KOSPI Plunges—When Will It Rebound?
- "They Said It's Impossible to Get—Already Selling for Triple the Price: Crowds Worldwide Line Up for $600 Luxury Watch"
- Real Estate PF Fees Reduced from 32 to 11 Types... Penalty and Maturity Extension Fees Abolished
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
Currently, Access Bio is designated as a high-risk investment stock.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
